SCHEMBL29673166

SCHEMBL29673166

CCOC(=O)C(OCC)OCCc1ccc(F)cc1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.40
POLB P06746 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
ALDH1A1 P00352 1/20 0.39
ALOX15 P16050 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
HSD17B10 Q99714 1/20 0.39
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
CDC7 O00311 1/20 0.38
DBF4 Q9UBU7 1/20 0.38
P2RX7 Q99572 6/20 0.37
MAPT P10636 2/20 0.37
LMNA P02545 1/20 0.37
TP53 P04637 1/20 0.37
IL1B P01584 1/20 0.37
MC4R P32245 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24542976 1.00 HTT (0.41) HTTSMN1; SMN2L3MBTL1POLBCYP3A4
SCHEMBL6695072 0.76 L3MBTL1 (0.48) HTTSMN1; SMN2L3MBTL1POLBCYP3A4
SCHEMBL6695069 0.75 ALDH1A1 (0.47) HTTSMN1; SMN2L3MBTL1POLBCYP3A4
SCHEMBL29660103 0.74 CYP3A4 (0.49) HTTSMN1; SMN2L3MBTL1POLBCYP3A4
SCHEMBL3801839 0.74 HTT (0.46) HTTSMN1; SMN2L3MBTL1POLBCYP2C9
SCHEMBL27611364 0.74 L3MBTL1 (0.45) HTTSMN1; SMN2L3MBTL1POLBCYP3A4
SCHEMBL5593462 0.71 NR3C2 (0.47) CDC7DBF4
SCHEMBL27830902 0.70 PIN1 (0.43) CYP3A4ALDH1A1MAPTLMNAKMT2A
SCHEMBL13886136 0.70 ALDH1A1 (0.45) HTTSMN1; SMN2L3MBTL1POLBCYP3A4
SCHEMBL5004400 0.69 CASP1 (0.41) SMN1; SMN2POLBCYP2C9NPSR1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114644631-A KRAS G12C protein mutation inhibitor, preparation method thereof, pharmaceutical composition and application thereof 上海维申医药有限公司 2022-06-21 CN disclosed